PR Newswire BiotechnologyQwen · 实盘不做把握 9/10不做原因:不是事件🔁 +1 同一事件
北京时间·🕒 发布 20:00:00·⟳ 抓取 20:00:51 +51s·⚡ 决策 08-27 20:01:46 +55s·61.1 天前
PTC Therapeutics宣布将参加三场投资者会议（Wells Fargo、Cantor、Morgan Stanley）
该公告是例行IR日程通知，宣布高管将参加三场投资者会议，不含任何新增事实、管线数据、监管进展、财务指引或业务合作信息，不构成可交易催化。
📄 原文PR Newswire Biotechnology↗ 原文
PTC Therapeutics to Participate in Upcoming Investor Conferences
WARREN, N.J., Aug. 27, 2026 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that its executives w…
不做 PTC Therapeutics（PTCT.US）
公告仅为投资者会议日程安排通知，不含任何新增业务事实、管线进展、监管动态或财务信息，不构成可交易催化，无方向、无edge。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
结论摘要
PTC Therapeutics于2026年8月27日发布PR Newswire公告，仅宣布其高管将在9月10日至15日参加Wells Fargo、Cantor和Morgan Stanley三场医疗健康投资者会议并做演讲。公告不包含任何新管线数据、临床结果、监管进展、财务指引、合作交易或其他实质性业务信息。这是标准的IR日程通知，历史上此类公告对股价无可测量的方向性影响。无催化、无方向、无edge，判定不做。
🔎 新鲜度:最早出现 2026-08-27 · 扩散 low · price-in 风险 low ↗
先例如何影响了这次决策
对本次决策的影响:无先例影响决策；本事件本身无催化价值，无需先例支撑
方向:无方向性先例可参考
涨幅量级:无
形态:无
工具执行结果 · 成功 1 · 降级 0 · 失败 0 · 取消 0
- fetch_decision_experience 成功 stock_tools HTTP · 2,422 ms
{
原文全文
展开原文 · 1,508 字
WARREN, N.J., Aug. 27, 2026 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that its executives will speak at the following conferences:
Wells Fargo 21st Annual Healthcare Conference
Thursday, Sept. 10 at 9:30 a.m. ET
2026 Cantor Global Healthcare Conference
Friday, Sept. 11 at 8:35 a.m. ET
Morgan Stanley 24th Annual Global Healthcare Conference
Tuesday, Sept. 15 at 9:15 a.m. ET
The presentations will be webcast live on the Events and Presentations page under the Investor section of the PTC Therapeutics website at https://ir.ptcbio.com/events-presentations and will be archived for 30 days following the presentation.
About PTC Therapeutics, Inc.
PTC is a global biopharmaceutical company dedicated to the discovery, development and commercialization of clinically differentiated medicines for children and adults living with rare disorders. PTC is advancing a robust and diversified pipeline of transformative medicines as part of its mission to provide access to best-in-class treatments for patients with unmet medical needs. The company's strategy is to leverage its scientific expertise and global commercial infrastructure to optimize value for patients and other stakeholders. To learn more about PTC, please visit www.ptcbio.com and follow us on LinkedIn, X, Instagram and Facebook.
For more information, please contact:
Investors:
Ellen Cavaleri
+1 (615) 618-8228
[email protected]
Media:
Jeanine Clemente
+1 (908) 912-9406
[email protected]
SOURCE PTC Therapeutics, Inc.
Wells Fargo 21st Annual Healthcare Conference
Thursday, Sept. 10 at 9:30 a.m. ET
2026 Cantor Global Healthcare Conference
Friday, Sept. 11 at 8:35 a.m. ET
Morgan Stanley 24th Annual Global Healthcare Conference
Tuesday, Sept. 15 at 9:15 a.m. ET
The presentations will be webcast live on the Events and Presentations page under the Investor section of the PTC Therapeutics website at https://ir.ptcbio.com/events-presentations and will be archived for 30 days following the presentation.
About PTC Therapeutics, Inc.
PTC is a global biopharmaceutical company dedicated to the discovery, development and commercialization of clinically differentiated medicines for children and adults living with rare disorders. PTC is advancing a robust and diversified pipeline of transformative medicines as part of its mission to provide access to best-in-class treatments for patients with unmet medical needs. The company's strategy is to leverage its scientific expertise and global commercial infrastructure to optimize value for patients and other stakeholders. To learn more about PTC, please visit www.ptcbio.com and follow us on LinkedIn, X, Instagram and Facebook.
For more information, please contact:
Investors:
Ellen Cavaleri
+1 (615) 618-8228
[email protected]
Media:
Jeanine Clemente
+1 (908) 912-9406
[email protected]
SOURCE PTC Therapeutics, Inc.
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。